Skip to main content
. 2017 Aug 16;8(44):77963–77974. doi: 10.18632/oncotarget.20276

Table 5. Pooled HR and 95% CIs of microRNA 27a rs895819.

Outcome Model No. of studies No. of patients HR (95% CI) P-value Heterogeneity (I2, P-value)
OS CT vs TT 6 3235 1.133 (0.923, 1.391) 0.232 56.8%, 0.041
CC vs TT 7 3909 1.296 (1.027, 1.636) 0.029 54.3%, 0.041
CC + CT vs TT 5 3135 1.176 (0.916, 1.509) 0.204 68.9%, 0.012
CC vs CT + TT 3 1953 1.220 (0.975, 1.526) 0.082 9.8%, 0.330
RFS CT vs TT 2 948 1.117 (0.892, 1.400) 0.335 0.0%, 0.891
CC vs TT 2 948 0.979 (0.762, 1.256) 0.866 0.0%, 0.558
CC + CT vs TT 2 948 1.091 (0.899, 1.323) 0.380 0.0%, 0.791

OS: overall survival, RFS: recurrence-free survival.